Hoffman

Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development

Retrieved on: 
Thursday, September 21, 2023

He will be a member of Bluejay’s Executive team, reporting to Keting Chu, Founder and CEO of Bluejay Therapeutics.

Key Points: 
  • He will be a member of Bluejay’s Executive team, reporting to Keting Chu, Founder and CEO of Bluejay Therapeutics.
  • “I am delighted to welcome Chris to the senior leadership team at Bluejay”, stated Mrs. Chu.
  • “Chris has an outstanding track record in business & corporate development with both public and private biotech and pharma companies.
  • Before joining Bluejay, he served as VP, Business & Corporate development at LEXEO Therapeutics, where he led all business development, strategic transactions and played a significant role in the company’s capital raising activities.

Hoffman Financial Group Announced as Official Partner of the Georgia Bulldogs®

Retrieved on: 
Wednesday, September 6, 2023

ATLANTA, Sept. 6, 2023 /PRNewswire/ -- Hoffman Financial Group, a leading name in comprehensive retirement planning and financial services, proudly announces its official partnership with the Georgia Bulldogs®, marking a powerful collaboration that will bring exceptional benefits to both Georgia fans and clients of Hoffman Financial Group alike.

Key Points: 
  • ATLANTA, Sept. 6, 2023 /PRNewswire/ -- Hoffman Financial Group, a leading name in comprehensive retirement planning and financial services, proudly announces its official partnership with the Georgia Bulldogs®, marking a powerful collaboration that will bring exceptional benefits to both Georgia fans and clients of Hoffman Financial Group alike.
  • The partnership with the Georgia Bulldogs® embodies the spirit of teamwork, excellence, and achievement that Hoffman Financial Group values.
  • This partnership aligns perfectly with our values at Hoffman Financial Group as we strive to provide our clients with the tools and strategies they need to secure a prosperous financial future," stated Chris Hoffman, Founder of Hoffman Financial Group.
  • To celebrate this significant partnership, Hoffman Financial Group invites everyone to embrace their official tagline: "Come Build Your Financial Dynasty with Hoffman Financial Group."

HOFFMAN & ASSOCIATES ANNOUNCES MULTI-CITY EXPANSION AS IT CELEBRATES ITS 30TH ANNIVERSARY

Retrieved on: 
Monday, June 5, 2023

WASHINGTON, June 5, 2023 /PRNewswire/ -- Hoffman & Associates, a nationally recognized developer and industry leader that specializes in mixed-use and residential communities, today announced its expansion into two new markets, Charlotte, NC and Richmond, VA, as the company celebrates its 30th anniversary.

Key Points: 
  • "As we celebrate our 30th anniversary, I am proud of all that Hoffman & Associates has accomplished over the past three decades.
  • "Following the completion of Hoffman & Associates' largest project to date, The Wharf, we continue to focus on putting community first by creating inclusive, sustainable and innovative neighborhoods.
  • With that, we are proud to announce our expansion into two new markets with our first projects in Charlotte, NC and Richmond, VA," said Shawn Seaman, President at Hoffman & Associates.
  • Hoffman & Associates was founded in 1993 with a single townhouse conversion in Washington, DC's Logan Circle neighborhood.

Thirty Madison names Caroline Hofmann Chief Business Officer to oversee the telehealth leader's continued expansion into women's specialty healthcare

Retrieved on: 
Wednesday, May 17, 2023

NEW YORK, May 17, 2023 /PRNewswire/ -- Thirty Madison, the specialty care company improving access, affordability, outcomes, and patient experience, has named Caroline Hofmann its chief business officer. In her new role, Hofmann will oversee all Thirty Madison businesses, lead the continued expansion of its women's health portfolio under Nurx, and focus on developing strategies that will improve patient outcomes and experiences while delivering on the company's path to profitability.

Key Points: 
  • Hofmann will oversee all Thirty Madison businesses, lead expansion in women's health, and develop business strategies to reach profitability
    NEW YORK, May 17, 2023 /PRNewswire/ -- Thirty Madison , the specialty care company improving access, affordability, outcomes, and patient experience, has named Caroline Hofmann its chief business officer.
  • Formerly head of emerging businesses, Hofmann led the expansion of Nurx into new condition offerings to treat more women holistically across reproductive care, sexual health, dermatology, and mental health.
  • As chief business officer, Hofmann will oversee and lead operations of all Thirty Madison business lines, ensuring patient experience remains at the center of its broad range of offerings.
  • Hofmann joined Thirty Madison from Republic, a platform that democratizes access to private investments, where she served as Chief Operating Officer.

Hoffman & Associates Announces Mary Beth Avedesian as Senior Vice President of Development

Retrieved on: 
Tuesday, April 11, 2023

The larger development is intended to add an active and pedestrian-friendly area to the vibrant neighborhood that fosters community, sustainability and innovation.

Key Points: 
  • The larger development is intended to add an active and pedestrian-friendly area to the vibrant neighborhood that fosters community, sustainability and innovation.
  • View the full release here: https://www.businesswire.com/news/home/20230411005322/en/
    Mary Beth Avedesian, Senior Vice President of Development, Hoffman & Associates (Photo: Hoffman & Associates)
    “Following the recent delivery of the final phase of The Wharf this past Fall and our strategic expansion across the Mid-Atlantic and Southeast, Hoffman & Associates is continuing to grow our leadership team,” said Maria Thompson, Chief Operating Officer of Hoffman & Associates.
  • Avedesian joins Hoffman & Associates from B.F. Saul Company, where she served as Senior Vice President of Acquisitions and Development.
  • I look forward to bringing my expertise to the dynamic West Falls neighborhood development, along with 4600 Fairfax Drive, an exciting multifamily development in Arlington, while supporting Hoffman & Associates’ continued growth into Northern Virginia and beyond,” said Avedesian.

Hofmann Sausage Company New Product Drop, Korean BBQ Jerky

Retrieved on: 
Wednesday, January 11, 2023

SYRACUSE, N.Y., Jan. 11, 2023 /PRNewswire/ -- Hofmann Sausage Company announces the production release of Korean Style BBQ Flavor Smoked Pork Jerky.

Key Points: 
  • SYRACUSE, N.Y., Jan. 11, 2023 /PRNewswire/ -- Hofmann Sausage Company announces the production release of Korean Style BBQ Flavor Smoked Pork Jerky.
  • This jerky is the first pork jerky product to be sold under the Hofmann brand.
  • Other jerky products by the company include Prime Rib Smoked Beef Jerky, Cherry Maple Smoked Beef Jerky, and Honey BBQ Smoked Beef Jerky.
  • For more information on Hofmann Sausage Company, contact Rebecca Baker, Chief Marketing Officer, 315-437-7257, or visit https://hofmannsausage.com .

Ineke Arts Wins Global Award for Excellence in the Executive Search and Leadership Consulting Profession

Retrieved on: 
Tuesday, November 15, 2022

LONDON, Nov. 15, 2022 /PRNewswire-PRWeb/ -- Today at their annual AESC Global Conference in London, the Association of Executive Search and Leadership Consultants (AESC) recognized Ineke Arts, Partner, Hoffman, member of IIC Partners, with the AESC Award of Excellence.

Key Points: 
  • Awarded since 2000, the AESC Award of Excellence honors individuals at the height of their careers who have made significant, outstanding contributions to the executive search and leadership consulting profession.
  • Serving both clients and candidates exceeding their expectations remains my absolute priority, whether in Executive Search, Executive Interim Management or Leadership Assessment.
  • Karen Greenbaum, AESC President & CEO, said: "Through her commitment to excellence in the executive search and leadership consulting profession, Ineke Arts embody AESC's purposededicated to strengthening leadership worldwide.
  • After an initial career in the corporate world, Ineke joined the executive search and leadership consulting profession, and founded Hoffman in 1987, a Belgium-based member of IIC Partners providing executive search, executive interim management and leadership assessments at European and global level.

UnityLab Secures $4.5 Million Series A Funding to Accelerate Growth, Add Jobs and Expand Manufacturing Operations in Dushore, Pennsylvania

Retrieved on: 
Thursday, September 29, 2022

The company has a mission to revitalize manufacturing and to enable innovation in small towns across the United States.

Key Points: 
  • The company has a mission to revitalize manufacturing and to enable innovation in small towns across the United States.
  • Funding was led by Advantage Capital to support the companys growth as it continues to scale operations and create new jobs at its headquarters and manufacturing facility in Dushore, Pennsylvania.
  • The company plans to add as many as 150 jobs while making a significant continued investment in hiring over the next several years.
  • We are thrilled to have this financing and close our Series A round, said UnityLab CEO Jonathan Benjamin.

Carbon Title Challenges Real Estate Industry To Decarbonize Before It's Too Late; Unveils Platform to Motivate Change through Radical Transparency

Retrieved on: 
Thursday, September 15, 2022

PORTLAND, Ore., Sept. 15, 2022  /PRNewswire/ -- Carbon Title today unveiled the first decentralized platform designed to bring radical transparency to decarbonization efforts within the real estate sector, which is responsible for nearly 40% of greenhouse gas emissions worldwide. The industry has a historic opportunity to reduce carbon emissions, but until now, property owners, contractors, and developers have not been properly equipped to effectively reduce their emissions, particularly in building materials and construction.

Key Points: 
  • Carbon Title's easy-to-use tools will not only enable but also motivate the real estate industry to achieve its carbon neutral goals by marrying intuitive design with blockchain technology.
  • The real estate industry is facing a near impossible task: Increase construction output to meet growing housing and infrastructure demands while simultaneously fighting climate change by self-regulating and reducing carbon emissions.
  • "I've spent years in the real estate and construction industries and know how daunting decarbonization is for the industry," said Miles Haladay, co-founder at Carbon Title.
  • Based in Portland, OR, and founded in 2021 by Miles Haladay and Trevor Dryer, Carbon Title is the first decentralized platform bringing radical transparency to decarbonizing the real estate sector.

Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer

Retrieved on: 
Wednesday, February 2, 2022

SAN MATEO, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a private biopharmaceutical company focused on the development of innovative cures for infectious diseases, today announced that Nancy Shulman, M.D., joined Bluejay as chief medical officer, bringing over 20 years of clinical development experience with her to Bluejay Therapeutics.

Key Points: 
  • SAN MATEO, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a private biopharmaceutical company focused on the development of innovative cures for infectious diseases, today announced that Nancy Shulman, M.D., joined Bluejay as chief medical officer, bringing over 20 years of clinical development experience with her to Bluejay Therapeutics.
  • Prior to Bluejay, Dr. Shulman worked at Roche, Genentech, AbbVie, and most recently at Ambys Medicines, where she was the vice president of translational medicine.
  • Prior to joining industry, Nancy was an NIH-funded clinical/translational HIV researcher at Stanford University and was on the faculty in the Division of Infectious Diseases.
  • Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.